drugset / Trial / NCT03585426
Vancomycin in the Target Site Treatment of Intracranial Infection
RandomizedParallel-groupSingle-blindTreatment
Summary
Vancomycin, a novel intravenously administered antibiotic, currently plays a key role in the management of complicated multi-organism infections. However,current LC-MS/MS methods briefly describe parameters and the only reported internal standard was sometimes difficult to obtain. In our study,an updated LC-MS/MS method for the quantitative analysis of vancomycin in human serum was developed.
Timeline
- Start
- 2016-03
- Primary completion
- 2018-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vancomycin | Other / unclassified | 1 g | Intravenous |
Indications
No indication recorded.